Mercury Transit in Aquarius Has Big Plans? Lucky Breaks and Gains For Many!

Mercury, the planet of intellect, communication, logic, and adaptability, will transit into Aquarius on 11th February 2025. This powerful cosmic alignment will bring major transformations for people. Let's explore this in detail.
Mercury Transit in Aquarius Date and Time
Date - 11th February 2025 (Tuesday)
Time - 12:58 PM (IST)
On 11th February 2025, Mercury will transit into Aquarius, the sign ruled by Saturn. This transit might bring systematic approaches, precision, completions, and impactful communication in various aspects of life. Let's dive into what this means for each zodiac sign and explore useful and practical remedies to make the most of this transformative energy.
Also Read: Why Is Jupiter-Saturn Conjunction in 6th House a Game-Changer for You?
In astrology, Mercury is the planet of communication, intellect, logic, and wit. It influences how we think, speak, share information, and approach problem-solving. It plays a key role in areas such as business, relationships, and decision-making.
Being a fast-moving planet in astrology, Mercury has a powerful impact on technology, commerce, writing, and interpersonal relationships. When Mercury transits in Aquarius, it emphasizes innovation, forward-thinking, and community-driven growth.
Mercury governs the following areas:
• Communication and expression
• Logical reasoning and decision-making
• Business and commerce
• Technology and innovation
Mercury rules Gemini and Virgo signs. It shares a cordial relationship with the Sun and Venus.
It governs the day of Wednesday, which is associated with learning, clear communication, and productivity.
Mercury, also known as Budh in Vedic astrology, is often known as the messenger of the Gods, and it symbolizes quick thinking and adaptability.
When Mercury transits in Aquarius sign, which is governed by Saturn, it may bring balance between logic and discipline. However, its effects may vary for every zodiac sign depending on various factors such as house placement, planet and sign conjunctions, and so on.
Interested in knowing what the future holds for your personal life? If so, !
The Mercury transit predictions below are provided by renowned Vedic astrologer Astro Roli, who has over 10 years of experience in astrology. With deep knowledge of planetary movements and their effects, Astro Roli offers valuable insights into how this transit may impact each zodiac sign. Let's dive in and explore what changes and opportunities this celestial shift might bring for you!
Aries individuals may have the period of Mercury in Aquarius transit bring substantial gains for them by adopting a sharp and precise approach.
You may also have to make some extra efforts and face some challenges, but this will eventually cause professional gains and a logical mindset. Furthermore, it will ensure success and gains in many areas of life, mainly children and study.
Remedy:
Worship Lord Ganesha and chant his mantras.
Create a to-do list daily to maintain focus.
For Taurus natives, the period when Mercury transit in Aquarius happens will be of professional comfort and success.
This will be an ideal time to consider a job change. You may effectively communicate your ideas, resulting in professional recognition. Gains and opportunities from foreign lands are also on the horizon. Luck may favor you in professional matters, and your precise logic and successful planning could earn you the support of management.
Remedy:
Chant Mercury Mantra "Om Budhaya Namaha" and worship Lord Vishnu.
Engage in reflective journaling to gain clarity.
For Geminis, when Mercury transits in Aquarius, it could usher in a lucky time for you, especially when dealing with management and decision-makers.
While logical expression may require effort, the outcomes will likely be favorable. Opportunities for short and successful business trips could also lead to gains and success.
Remedy:
Chant Vishnu Sahasranama and Vishnu Kavacham.
Take short nature walks to stay grounded.
The Mercury transit in Aquarius 2025 may not be very favorable for Cancerians.
Relying on logical and analytical capabilities may result in sudden and unexpected losses, especially in dealings with foreign lands. Professionally, you could feel stagnated and face unexpected and sudden challenges. Express yourself precisely and stick to principled communication for relief.
Remedy:
Chant Ganesh mantras and Mercury Beej Mantra - Aum Braam Breem Broum Sah Budhaya Namah.
Dedicate time to self-care, relaxation activities, and mindfulness techniques.
Leos could experience financial growth during the transit of Mercury in Aquarius 2025 period through effective analytical planning.
Luck may favor you at this time, and decision-makers and management may support and encourage you. Strategic thinking and planning could develop within you, proving instrumental in the future.
Remedy:
Chant 'Aum Bum Budhaya Namah' or 'Aum Ayeem Shreem Shreem Budhaye Namah' on Wednesdays.
Pursue creative projects to boost confidence and channel energy positively.
For Virgo natives, the Mercury transit in Aquarius will be a period of professional hard work.
You could face challenging times in areas of applying logic, so avoid being extra critical, as it might lead to losses. Focus on analytical planning and strategy-making during this period and avoid any form of investment that could result in unfavorable outcomes.
Remedy:
Donate green food items like lentils and green vegetables to someone needy on a Wednesday.
For Libra sign natives, the Mercury transit effects could bring gains and favor from luck.
However, avoid being overly critical or excessively logical, as this might lead to unfavorable events. Financial gains and happiness from children may be expected. It's also a good time to enhance your public image. Analytical thinking could bring you gainful opportunities. Investing in the heavy goods and machinery sector may prove beneficial.
Remedy:
Chant Lord Ganesh's mantras and Vishnu Sahastranama.
Engage in creative activities.
During the Mercury transit in Aquarius (11 Feb), Scorpio zodiacs may experience sudden gains.
However, challenges at work and home might arise if you are overly critical. Use this time well for strategic planning and analysis. Gains from foreign lands will be likely, and this period could bring professional comfort.
Remedy:
Wear or use Budh Yantra for auspicious results from Mercury.
For Sagittarians, the transit of Mercury in Aquarius 2025 may be a period to put efforts into areas of communication to express yourself effectively.
Short business trips for growth and development are also likely at this time. This is also a favorable time for spiritual growth. Gains could come through communication, presentations, and effective dissemination of ideas.
Remedy:
Donate green lentils to a guard or security personnel on a Wednesday morning.
Capricorn individuals, during the Mercury in Aquarius transit 2025, might experience challenges and be required to put extra effort into analytics and communication.
It will be advisable to take balanced risks to avoid unfavorable outcomes. However, luck may still favor you, and you could receive support from management personnel. Unexpected gains are possible if you stay calm and avoid overthinking.
Remedy:
Chant Vishnu Kavach.
Seek mentorship or guidance from experienced professionals.
For Aquarians, the Mercury transit 2025 in their own sign, could be a time of happiness and contentment, particularly for children.
You may also gain a new logical perspective. It'll be an excellent time to enhance your public image, gain from partnerships, and enjoy happiness in your personal life. Sudden opportunities and the application of deep-rooted logic may lead to favorable outcomes.
Remedy:
Feed soaked green gram to birds.
For Pisces individuals, the effects of Mercury transit in Aquarius might not be very favorable.
Avoid strategic investments and over-analyzing, as these could lead to losses and stress in your personal and public life. Take calculated risks and focus on maintaining harmony in your personal life.
Remedy:
Chant Ganesh Chalisa.
Practice mindfulness and meditation.
*Note: These are the general forecasts for the Mercury transit in Aquarius 2025. For personalized predictions, you may consult with Astroyogi expert Astro Roli.#Astrology

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

Forbes

7 hours ago

• Forbes

White House Aims To Halt Fantastical NASA Missions Across Solar System

The New Horizons spacecraft sends back its sensational snapshots of Jupiter, and its volcanic moon ... More Io, before the mission's close encounter with Pluto (Photo by: Photo12/Universal Images Group via Getty Images) Universal Images Group via Getty Images The White House bid to terminate NASA's leading-edge flights of exploration 'across the solar system' threatens to explode American leadership in discoveries that have reshaped civilization since the rise of the first Space Age, says one of the world's top planetary scientists. As space powers across the continents vie to map and image planets and moons, comets and ice-worlds circling the sun, slashes to NASA's funding would represent a great leap backward, crippling it even as rivals race ahead, says Alan Stern, a one-time leader at NASA and a globally acclaimed space scientist. The president's new proposed budget drastically cuts appropriations for NASA, with outlays for its planetary science missions—the exploration of Pluto and other celestial worlds by space-borne rockets and robots, cameras and telescopes—axed almost in half. Now facing the guillotine—inexplicably—are constellations of technologically advanced space probes developed by NASA and spearheading scientists across America, including the Juno imager now orbiting Jupiter, the Mars Odyssey and Maven spacecraft gliding above Mars and the asteroid hunter OSIRIS-Apophis. NASA's Mars Odyssey spacecraft, in orbit around Mars, is one of the leading-edge explorers slated to ... More be terminated by the White House. Shown here is an artist's impression of the orbiter. (Photo) Getty Images 'Incredibly, this budget proposes to turn off 55 perfectly working, productive spacecraft across the solar system,' Dr. Stern, who once headed NASA's Science Mission Directorate, tells me in an interview. Stern took up that post after conceiving and designing one of the American space agency's most sensational missions ever - the New Horizons spacecraft that aced a close approach with Pluto while sending back fantastical images of the otherworldly orb and its moons - a miniature planetary system that generated billions of hits when it began beaming down across NASA's website. While New Horizons continues its super-speed flight through the outer solar system, charting the mysterious frozen reaches of the Kuiper belt, the president's plan calls for the spacecraft to be cast away. Abandoning the $900-million mission in order to recoup the minimal costs of its ongoing operation makes no sense economically or scientifically, Stern says. The robotic photographer New Horizons images Pluto as it speeds through the outer solar system ... More (Photo by NASA/APL/SwRI via Getty Images) Getty Images 'With New Horizons,' he says, 'there are a lot of important scientific objectives still ahead, things no other spacecraft can do.' 'Terminating this mission would also represent a tragic loss of soft power projection for the U.S.' The Horizons craft, and its array of next-generation cameras and spectrometers, is exploring a region beyond Pluto that no other human-created probe has ever entered, with a treasure trove of potential discoveries waiting. 'This would be like sending a message to [Christopher] Columbus to sink his ships while they were in North America,' Stern tells me, upending a new age of discovery. 'With New Horizons, we have the power and the fuel to run this mission for another 20 years … and we have more Kuiper belt objects to explore.' The White House, in issuing its slashed budget plan for NASA, never provided a logical rationale for torpedoing some of the agency's world-leading missions to survey and image the solar system. Its inscrutable sinking of some of these vanguard voyages was unveiled with the terseness of a telegram: 'Operating missions that have completed their prime missions (New Horizons and Juno) and the follow-on mission to OSIRIX-REx, OSIRIS-Apophis Explorer, are eliminated.' The asteroid-hunter OSIRIS spacecraft, shown here at the Kennedy Space Center in Florida, is one of ... More the trailblazers set to be terminated by the White House. (Photo by Bruce Weaver / AFP) (Photo by BRUCE WEAVER/AFP via Getty Images) AFP via Getty Images The OSIRIS spacecraft, which had been slated to rendezvous with the closely approaching Apophis asteroid ahead, is a precursor mission to defending the Earth's eight billion citizens against doomsday cosmic strikes by colossal comets or asteroids of the future. The robotic photographer Juno has snapped an endless kaleidoscope of imagery as it floats around Jupiter. Scientists at NASA's Jet Propulsion Lab have posted raw impressions of the orb and its moons and invited 'citizen scientists' to Photoshop and launch them across the cybersphere. In the process, they are becoming part of the spacefaring civilization that is spreading out across the globe. Model of the $1-billion Juno spacecraft, which is now orbiting and photographing Jupiter (Photo by ... More) Getty Images During its own space odyssey, New Horizons has astounded stargazers, students and scholars worldwide with its technicolor panoramas of Pluto, covered in surreal ice-fields and cryo-volcanoes, and its age-old companion Charon. The twin netherworlds—named after the mythical Greek god of the underworld and the pilot who shuttled souls across the river Styx—circle more than five billion kilometers distant from the sun, along an orbit that Stern's Pluto expedition took nine years to reach. Now, even as it whizzes beyond all of the classical planets, New Horizons, and its future, has entered the purgatory of potential excommunication by mission controllers—and their masters—six worlds away. The New Horizons spacecraft, now speeding through the outer solar system, could be jettisoned under ... More a White House plan that would destroy American leadership in planetary science missions. (Photo by Heritage Art/Heritage Images via Getty Images) Heritage Images via Getty Images 'This is a vast and tragic mistake,' Stern says, 'because the issue is larger than just NASA, it also affects U.S. world leadership [and] responsible government that protects taxpayers from waste like this.' The administration's crash-and-burn dismissal of the solar system's trailblazing robotic discoverers has triggered trepidation across NASA, whose ranks of pioneering scientists are likewise set to be culled. Within NASA, Alan Stern is a pole star of cutting-edge exploration, helping guide more than two dozen missions. After his New Horizons spacecraft rendezvoused with Pluto, the agency bestowed its highest honor on him - the NASA Distinguished Public Service Medal. 'Stern led the team that returned remarkable imagery and other data from the Pluto system last summer, generating headlines worldwide and setting a record for the farthest world ever explored,' NASA's leaders said. "New Horizons represents the best of humanity and reminds us of why we explore,' added Jim Green, NASA's director of planetary science. "The first flyby of Pluto is a remarkable achievement.' Being given the chance to lead the close encounter with Pluto, Stern said on accepting the award, 'has been the greatest honor of my lifetime.' Around the same time, NASA film-makers paid tribute to Stern, his 2000+ Pluto mission colleagues, and the target of their interplanetary expedition in the captivating documentary ' The Year of Pluto .' Stern has himself chronicled his trek across the twilight reaches of the star system in a stream of fascinating books, including Pluto and Charon: Ice Worlds on the Ragged Edge of the Solar System and Chasing New Horizons, and in a torrent of acclaimed papers . Scholar Stern predicts that if the White House's proposed death sentence for flotillas of pathfinding space missions is actually carried out, that would mark the decline and fall of NASA's planetary science breakthroughs, and the comparative rise of its competitors in the renewed space race of the 2020s. If NASA's funding and inter-planet journeys are decimated, he tells me, 'These cuts will absolutely destroy U.S. leadership in all the space sciences.' 'This is tragically misguided.' The potential death knell for an armada of space discovery missions has been reverberating not just across NASA, but also throughout the U.S. universities that help conceive or design these flights. 'Certainly termination of the New Horizons mission would be terrible,' says Kip Hodges , who as founding director of Arizona State University's School of Earth and Space Exploration helped transform the university into one of the top American space studies centers. 'This a real frontier mission at this point,' he tells me in an interview, 'delivering important new information about distant parts of our Sun's heliosphere.' Congress has the power to save NASA and its leading-edge robotic explorers across the solar system ... More (Illustration by Tobias Roetsch/Future Publishing via Getty Images) Future Publishing via Getty Images Professor Hodges , one of the top space scholars in the U.S., predicts that the Swords of Damocles now hanging above New Horizons and other new-frontier flights could still be lifted. If the White House plan to cut away at NASA and its revolutionary planetary scouting missions were enacted as is, he predicts, 'a great many folks in industry, the NASA labs, and academia will be disappointed.' Yet he adds that 'the budget for NASA evolves over several stages,' with the president's initial proposal just one of competing models—one that could be rejected as the Senate and House of Representatives look afresh at NASA's missions, goals and funding. After the twin chambers reach a consensus on reshaping NASA for the next phase of its evolution, Professor Hodges adds, 'Quite often, the appropriated budget is not the president's budget.' That means space aficionados across America who seek to overturn the president's capital sentence on NASA's boundary-breaking missions have a clear channel of recourse, Stern says. Would-be petitioners for a reprieve, he advises, 'should contact their elected representatives in Congress and tell them this is a huge mistake.'

Business Upturn

10 hours ago

• Business Upturn

Novo Nordisk A/S: CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in New England Journal of Medicine

By GlobeNewswire Published on June 22, 2025, 18:00 IST Data presented simultaneously at the American Diabetes Association's ® 85 th Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing weight loss interventions 1 85 Scientific Sessions, showed mean weight reduction in the highest range of efficacy observed with existing weight loss interventions When adhering to treatment, weight loss of ≥5%, ≥20%, ≥25%, and ≥30% was observed in 97.6%, 60.2%, 40.4% and 23.1% of patients respectively at 68 weeks 1 * The REDEFINE clinical programme is ongoing to further investigate efficacy and safety of CagriSema, including recently initiated REDEFINE 112 Bagsværd, Denmark, 22 June – Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk's phase 3 REDEFINE 1 trial evaluating the efficacy and safety of investigational CagriSema plus lifestyle interventions for weight loss in adults with obesity or overweight who have a weight-related medical complication and without diabetes.1 REDEFINE 1 met its co-primary endpoints and achieved statistically significant and clinically meaningful weight loss at 68 weeks in patients taking CagriSema versus placebo.1 These data, along with the related phase 3 REDEFINE 2 study conducted in adults with overweight or obesity and type 2 diabetes, were presented today during a scientific symposium at the American Diabetes Association's (ADA) 85th Scientific Sessions and published in NEJM . 'In REDEFINE 1, participants saw significant and clinically meaningful weight loss under a protocol that allowed investigators to maintain patients on a submaximal dose if deemed best for the patient. We also witnessed low, single-digit discontinuation rates due to adverse events in both REDEFINE 1 and 2,' said Martin Holst Lange, executive vice president and head of Development at Novo Nordisk. 'These results reinforce our confidence in CagriSema, and we continue to study the potential of this combination through the REDEFINE trials.' CagriSema is an investigational product that combines the GLP-1 RA, semaglutide, with an amylin analogue, cagrilintide. The REDEFINE 1 trial found that treatment with CagriSema resulted in greater weight loss of 22.7% at 68 weeks versus 2.3% in the placebo group if all patients adhered to treatment.1* When evaluating the treatment effect regardless of adherence, those treated with CagriSema achieved statistically significant weight loss of 20.4% at 68 weeks versus 3.0% for the placebo group.1** In addition, a supportive secondary analysis showed that half (50.7%) of trial participants with obesity treated with CagriSema reached the threshold for non-obesity (BMI < 30 kg/m2) at the end of treatment, from a mean BMI of 38 kg/m2 at the start of treatment. In the placebo group,10.2% reached that threshold at 68 weeks.1 Select confirmatory secondary endpoints showed that if all participants adhered to treatment 40.4% of those receiving CagriSema achieved a body weight reduction of ≥25%.* Additionally, 23.1% lost ≥30% of their body weight.1* When applying the treatment policy estimand, 34.7% of participants treated with CagriSema achieved ≥25% body-weight reduction and 19.3% achieved ≥30% body-weight reduction.1** In a prespecified analysis of 252 participants, the relative reduction in fat and lean soft-tissue mass from baseline to week 68 was -35.7% (fat mass) and -14.4% (lean soft-tissue mass) for those treated with CagriSema versus –5.7% and –4.3% for the placebo group, respectively.1 'In REDEFINE 1, CagriSema provided weight loss in the highest range of efficacy observed with existing weight loss interventions,' said lead investigator Timothy Garvey, MD, professor of medicine and director of the Diabetes Research Center at the University of Alabama at Birmingham. 'Investigators were allowed some flexibility in dose adjustments to balance efficacy and safety, but regardless of dose adjustments participants lost significant weight. These findings are relatable to clinical practice, where dosing is often adjusted based on individual needs and clinical judgement.' Safety data generated in the REDEFINE 1 and 2 trials were comparable with the GLP-1 RA class. Overall, discontinuation rates due to adverse events were low, with 6% for CagriSema versus 3.7% for placebo in REDEFINE 1 and 8.4% with CagriSema versus 3% with placebo in REDEFINE 2.1,3 In REDEFINE 1, adverse events were mainly gastrointestinal (79.6% in the CagriSema group vs. 39.9% with placebo), including nausea (55% vs. 12.6 %), constipation (30.7% vs. 11.6%), vomiting (26.1% vs. 4.1%) and were mostly transient and mild-to-moderate in severity.1 Results from REDEFINE 2, a phase 3 study that evaluated the efficacy and safety of CagriSema plus lifestyle interventions in adults with obesity and type 2 diabetes (T2D), were also simultaneously presented during a scientific symposium at the ADA's Scientific Sessions and published in NEJM .3 In REDEFINE 2, if all participants adhered to treatment, the estimated mean change in body weight from baseline to week 68 was –15.7% with CagriSema versus –3.1% with placebo.3* When applying the treatment policy estimand, the estimated mean change in body weight from baseline to week 68 was –13.7% with CagriSema versus –3.4% with placebo.3** A greater proportion of participants receiving CagriSema, compared with placebo, reduced their body weight by > 5% (83.6% vs. 30.8% of participants), ≥10% (65.6% vs. 10.3%), ≥15% (43.9% vs. 2.4%), and ≥20% (22.9% vs. 0.5%;).3 The safety results from CagriSema in REDEFINE 2 were similar to those reported in REDEFINE 1.3 The REDEFINE clinical programme will continue to assess the efficacy and safety of CagriSema. Most recently, Novo Nordisk initiated the REDEFINE 11 trial with the first patient visit occurring in early June 2025. REDEFINE 11 will explore further weight loss potential and safety of CagriSema 2.4 mg / 2.4 mg through a longer trial duration and other protocol changes compared to REDEFINE 1 and 2. * Based on the trial product estimand; this estimand estimates what the effect would be if all participants adhered to treatment ** Based on the treatment policy estimand: treatment effect regardless of treatment adherence About CagriSema CagriSema is being investigated by Novo Nordisk as a once-weekly subcutaneous injectable treatment for adults with overweight or obesity (REDEFINE programme) and as a treatment for adults with type 2 diabetes (REIMAGINE programme). CagriSema is a fixed-dose combination of a long-acting amylin analogue, cagrilintide 2.4 mg and semaglutide 2.4 mg. About the REDEFINE clinical trial programme REDEFINE is a phase 3 clinical development programme with once-weekly subcutaneous CagriSema in obesity. REDEFINE 1 and REDEFINE 2 have enrolled approximately 4,600 adults with overweight or obesity. REDEFINE 1 was a double-blind, placebo-and active-controlled 68-week efficacy and safety phase 3 trial of once-weekly CagriSema, cagrilintide 2.4 mg and semaglutide 2.4 mg versus placebo in 3,417 adults with obesity or overweight with one or more comorbidities and without type 2 diabetes. REDEFINE 2 was a double-blind, randomized, placebo- and controlled 68-week efficacy and safety phase 3 trial of once-weekly CagriSema versus placebo in 1,206 adults with type 2 diabetes and either obesity or overweight. Multiple REDEFINE clinical trials are currently underway including: REDEFINE 3, an event-driven cardiovascular outcomes phase 3 trial; REDEFINE 4 an 84-week head-to-head efficacy and safety phase 3 trial of once-weekly CagriSema versus once-weekly tirzepatide; and REDEFINE 11, a phase 3 trial with longer duration and other protocol changes compared to REDEFINE 1 and 2. About obesity Obesity is a serious chronic, progressive, and complex disease that requires long-term management.4–6 One key misunderstanding is that this is a disease of just lack of willpower, when in fact there is underlying biology that may impede people with obesity from losing weight and keeping it off.4,6 Obesity is influenced by a variety of factors, including genetics, social determinants of health, and the environment.7,8 About Novo Nordisk Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and working to prevent and ultimately cure disease. Novo Nordisk employs about 77,400 people in 80 countries and markets its products in around 170 countries. For more information, visit , Facebook , Instagram , X , LinkedIn and YouTube . Contacts for further information References: Garvey WT, Blüher MD, Contreras CKO, et al. CagriSema in Adults with Overweight or Obesity. New England Journal of Medicine 2025. doi: 10.1056/NEJMoa2502081 A Research Study to Look at How Well CagriSema Helps People Living With Obesity Lose Weight and Maintain Weight Loss in the Long-term. Last Accessed: June 2025. Available at: Davies MJ, Harpreet S, Bajaj MD, et al. CagriSema in Adults with Overweight or Obesity and Type 2 Diabetes. New England Journal of Medicine 2025. Kaplan LM, Golden A, Jinnett K, et al. Perceptions of barriers to effective obesity care: results from the national action study. Obesity . 2018;26(1):61-69. Bray GA, Kim KK, Wilding JPH; World Obesity Federation. Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation. Rev . 2017;18(7):715-723. Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity. Endocr Pract . 2016;22 (Suppl 3):1-203. Centers for Disease Control and Prevention. Adult obesity facts. Last accessed: June 2025. Available at: World Obesity Federation. World Obesity Atlas 2023. Last accessed: June 2025. Available at: Attachment Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

Washington Post

2 days ago

• Washington Post

It turns out weather on other planets is a lot like on Earth

What do the clouds on Jupiter, dust storms on Mars and rainstorms on Titan all have in common? They look like they belong on Earth. As we venture through the universe, scientists are finding uncanny — and sometimes unexpected — hints of Earth on other planets and moons. Clouds on Jupiter swirl like ocean eddies on Earth, and dust storms that act like hurricanes can inundate Mars. Even though these celestial bodies can be hundreds of million miles away from us, the same laws of physics apply, and what happens there can help us learn more about worlds that humans have yet to visit.